Back to RTW INVESTMENTS, LP

SYRE
Showing 8 of 10 quarters

Position history for RTW INVESTMENTS, LP's holdings in SPYRE THERAPEUTICS INC

RTW INVESTMENTS, LP holds 4.2M shares of SYRE (SPYRE THERAPEUTICS INC), worth $210.4M as of 2026-Q1. SYRE represents 2.1% of RTW INVESTMENTS, LP's portfolio.

Current Value

$210.4M

Current Shares

4.2M

Total Value Change

+$133.8M

Total Shares Change

+913,636

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
4.2M
0.0%
$210.4M2.1%$40.07
0
2025-Q4
Increased
4.2M
+15.2%
$136.7M1.4%$31.88
55
2025-Q3
Unchanged
3.6M
0.0%
$60.7M0.7%$16.36
0
2025-Q2
Unchanged
3.6M
0.0%
$54.2M0.8%$15.22
0
2025-Q1
Unchanged
3.6M
0.0%
$58.4M0.9%$17.94
0
2024-Q4
Increased
3.6M
+11.2%
$84.3M1.3%$22.54
52
2024-Q3
Unchanged
3.3M
0.0%
$95.8M1.4%$28.49
0
2024-Q2
Increased
3.3M
+45.9%
$76.6M1.2%$23.51
64

Other major holders of SYRE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used